Coronavirus vaccine in India: Covaxin, Sputnik-V makers asked to submit revised proposals for human trials
Coronavirus COVID-19 vaccine tracker: Regarding Bharat Biotech’s Coronavirus vaccine candidate ‘Covaxin’, the SEC said that the design of phase 3 human trials was satisfactory “in principle”. (Reuters image) Coronavirus COVID-19 vaccine tracker: Pharmaceutical firms Dr Reddy’s Laboratories (DRL), Bharat Biotech, and Biological E (Bio E) have been directed by an expert committee set up under … Read more